Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score AnalysisFélix Ackermann, Mathilde Roumier, Romain Paule et al.|Journal of Clinical Immunology|2020Cited by 53
ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19Tiffany Pascreau, Marc Vasse, Sara Zia-Chahabi et al.|Thrombosis Research|2021Cited by 31
The ID NOW COVID-19, a high-speed high-performance assayÉric Farfour, C Amiel, Marianne Asso‐Bonnet et al.|European Journal of Clinical Microbiology & Infectious Diseases|2021Cited by 16
A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndromeTiffany Pascreau, Philippe Lassalle, Colas Tchérakian et al.|Critical Care|2021Cited by 15
The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosisTiffany Pascreau, Marc Vasse, Marie‐Christine Ballester et al.|Clinical Chemistry and Laboratory Medicine (CCLM)|2021Cited by 12